$PRSO

MoSys, Inc.

CIK:0000890394|SEC Filings

Condensed Consolidated Statements of Operations (Unaudited) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2026	Jun. 30, 2025	Jun. 30, 2026	Jun. 30, 2025
Net revenue
Total net revenue	$ 1,307	$ 2,220	$ 2,270	$ 6,089
Cost of net revenue	474	1,147	845	2,336
Gross profit	833	1,073	1,425	3,753
Operating expenses
Research and development	1,625	1,662	3,210	3,245
Selling, general and administrative	1,444	1,411	2,935	3,022
Software License Obligations		(223)		(223)
Total operating expenses	3,069	2,850	6,145	6,044
Loss from operations	(2,236)	(1,777)	(4,720)	(2,291)
Change in fair value of warrant liabilities	14	(29)	5	6
Other income (expense), net	2	(23)	(2)	(15)
Net loss	$ (2,220)	$ (1,829)	$ (4,717)	$ (2,300)
Net loss per share
Basic (in Dollars per share)	$ (0.16)	$ (0.31)	$ (0.37)	$ (0.39)
Diluted (in Dollars per share)	$ (0.16)	$ (0.31)	$ (0.37)	$ (0.39)
Shares used in computing net loss per share
Basic (in Shares)	14,058	5,977	12,842	5,862
Diluted (in Shares)	14,058	5,977	12,842	5,862
Product
Net revenue
Total net revenue	$ 1,244	$ 2,218	$ 1,911	$ 6,018
Services and other
Net revenue
Total net revenue	$ 63	$ 2	$ 359	$ 71

Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($) $ in Thousands	6 Months Ended
	Jun. 30, 2026	Jun. 30, 2025
Cash flows from operating activities:
Net loss	$ (4,717)	$ (2,300)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization	99	129
Stock-based compensation	317	266
Change in fair value of warrant liabilities	(5)	(6)
Inventory write-down	33
Shares issued for services		40
Other	(8)	(13)
Changes in assets and liabilities
Accounts receivable	920	(310)
Inventories	(573)	783
Prepaid expenses and other	(209)	(526)
Accounts payable	78	242
Right-of-use assets	38	73
Lease liabilities - operating	(65)	(43)
Deferred revenue, accrued expenses and other	169	(1,342)
Net cash used in operating activities	(3,923)	(3,007)
Cash flows from investing activities:
Purchases of property and equipment	(280)	(45)
Net cash used in investing activities	(280)	(45)
Cash flows from financing activities:
Proceeds from at-the-market sales of stock, net	4,668	1,512
Payment of deferred equity facility costs	(50)
Proceeds from option exercises	21	4
Repayment of financing leases		(47)
Net cash provided by financing activities	4,639	1,469
Net increase (decrease) in cash and cash equivalents	436	(1,583)
Cash and cash equivalents at beginning of period	2,886	3,344
Cash and cash equivalents at end of period	3,322	1,761
Noncash investing and financing activities:
Recognition of deferred equity facility costs	$ 240

Condensed Consolidated Balance Sheets - USD ($) $ in Thousands	Jun. 30, 2026	Dec. 31, 2025
Current assets
Cash and cash equivalents	$ 3,322	$ 2,886
Accounts receivable, net	306	1,219
Inventories, net	1,708	1,168
Prepaid expenses and other	407	195
Total current assets	5,743	5,468
Property and equipment, net	548	363
Right-of-use lease assets	105	143
Other	390	105
Total assets	6,786	6,079
Current liabilities
Accounts payable	757	679
Accrued expenses and other	883	540
Deferred revenue	74	8
Short-term lease liabilities	96	95
Total current liabilities	1,810	1,322
Long-term lease liabilities	32	97
Warrant liabilities	19	24
Total liabilities	1,861	1,443
Commitments and contingencies (Note 4)
Stockholders’ equity
Preferred stock, value
Common stock, $0.001 par value; 120,000 shares authorized; 15,041 and 10,055 shares issued and outstanding at June 30, 2026 and December 31, 2025, respectively	14	9
Exchangeable shares, no par value; unlimited shares authorized; 56 shares outstanding at June 30, 2026 and December 31, 2025
Issuable shares, none and 137 shares at June 30, 2026 and December 31, 2025, respectively		162
Additional paid-in capital	191,501	186,338
Accumulated deficit	(186,590)	(181,873)
Total stockholders’ equity	4,925	4,636
Total liabilities and stockholders’ equity	6,786	6,079
Series A Special Voting Preferred Stock
Stockholders’ equity
Preferred stock, value